Insider · CIK 0001673991

Hawryluk P. Kent

Reports to the SEC for 2 companies · CARMEL, IN

sec.gov

Transactions

Companies

Filings

CIK

0001673991

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-06	MBXMBX Biosciences, Inc.S Sale	Director, President & CEO	SSale	−607 sh	$29.54	−$17.9K	727,667
2026-03-13	MBXMBX Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+18.5K sh	$28.41	+$526K	486,777
2026-02-26	MBXMBX Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+28.8K sh	$16.00	+$460K	728,274
2026-02-26	MBXMBX Biosciences, Inc. · Stock option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−28.8K sh	—	—	91,668
2026-02-02	MBXMBX Biosciences, Inc.A Award	Director, President & CEO	AAward	+35.3K sh	—	—	699,506
2026-02-02	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+165K sh	—	—	164,500
2025-10-24	MBXMBX Biosciences, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+183K sh	$3.25	+$594K	664,256
2025-10-24	MBXMBX Biosciences, Inc. · Stock option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−183K sh	—	—	129,708
2025-10-20	MBXMBX Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+20K sh	$13.64	+$273K	468,277
2025-02-04	MBXMBX Biosciences, Inc.P Purchase	Director, President & CEO	PPurchase	+50K sh	$10.69	+$535K	448,277
2025-02-03	MBXMBX Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+243K sh	—	—	243,000
2024-09-16	MBXMBX Biosciences, Inc.C Conversion	Director, President & CEO	CConversion	+284K sh	—	—	481,397
2024-09-16	MBXMBX Biosciences, Inc.C Conversion	Director, President & CEO	CConversion	+116K sh	—	—	398,277
2024-09-16	MBXMBX Biosciences, Inc. · Series A Convertible Preferred StockC Conversion	Director, President & CEO	CConversion	−2.02M sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc. · Series A Convertible Preferred StockC Conversion	Director, President & CEO	CConversion	−346K sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc. · Series B Convertible Preferred StockC Conversion	Director, President & CEO	CConversion	−1.4M sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc. · Series B Convertible Preferred StockC Conversion	Director, President & CEO	CConversion	−77K sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc. · Series C Convertible Preferred StockC Conversion	Director, President & CEO	CConversion	−971K sh	—	—	0
2024-09-12	MBXMBX Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+120K sh	—	—	120,436
2018-01-29	MTVAMetaVia Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,800
2017-03-10	MTVAMetaVia Inc.P Purchase	Director	PPurchase	+25K sh	$9.47	+$237K	81,889
2017-03-10	MTVAMetaVia Inc. · Warrant to Purchase Common StockP Purchase	Director	PPurchase	+18.8K sh	$9.47	+$178K	18,750
2016-08-10	MTVAMetaVia Inc.C Conversion	Director	CConversion	+7,457 sh	—	—	7,457
2016-08-10	MTVAMetaVia Inc.J Other	Director	JOther	+816 sh	$6.71	+$5,472.014	8,273
2016-08-10	MTVAMetaVia Inc.C Conversion	Director	CConversion	+23.6K sh	$6.71	+$158K	31,889
2016-08-10	MTVAMetaVia Inc.P Purchase	Director	PPurchase	+25K sh	$10.00	+$250K	56,889
2016-08-10	MTVAMetaVia Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−7,457 sh	—	—	0
2016-08-10	MTVAMetaVia Inc. · 8% Convertible Subordinated Promissory NotesC Conversion	Director	CConversion	—	—	—	0
2016-08-04	MTVAMetaVia Inc. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
May 84
Hawryluk P. Kent0001193125-26-214574
SEC(opens sec.gov)
Mar 164
Hawryluk P. Kent0001193125-26-107268
SEC(opens sec.gov)
Feb 274
Hawryluk P. Kent0001193125-26-082562
SEC(opens sec.gov)
Feb 34
Hawryluk P. Kent0001193125-26-035582
SEC(opens sec.gov)
Oct 284
Hawryluk P. Kent0001193125-25-252404
SEC(opens sec.gov)
Oct 214
Hawryluk P. Kent0001193125-25-245411
SEC(opens sec.gov)
Feb 54
Hawryluk P. Kent0000950170-25-014494
SEC(opens sec.gov)
Sep 174
Hawryluk P. Kent0000950170-24-107527
SEC(opens sec.gov)
Sep 134
Hawryluk P. Kent0000950170-24-106441
SEC(opens sec.gov)
Jan 304
Hawryluk P. Kent0001596771-18-000014
SEC(opens sec.gov)

Companies

Address

C/O MBX BIOSCIENCES, INC. 11711 N. MERIDIAN STREET, SUITE 300

CARMEL, IN, 46032